Melissa A Kotterman

Title: Innovations by Melissa A Kotterman

Introduction

Melissa A Kotterman is an accomplished inventor based in Oakland, CA. She has made significant contributions to the field of gene therapy through her innovative work with recombinant adeno-associated viruses (rAAV). With a total of two patents to her name, her research focuses on enhancing the efficacy of gene delivery systems.

Latest Patents

Kotterman's latest patents include "Compositions and methods of treatment" and "Adeno-associated virus variants and methods of use thereof." Both patents detail the development of infectious rAAV virions that incorporate variant capsid proteins and heterologous nucleic acids. These innovations aim to improve the resistance of rAAV virions to human neutralizing antibodies, thereby enhancing their effectiveness in delivering gene products to target cells. The methods outlined in her patents provide a framework for administering these rAAV virions to individuals in need of gene therapy.

Career Highlights

Kotterman is affiliated with the University of California, where she continues her research in gene therapy and viral vector development. Her work has the potential to revolutionize treatments for various genetic disorders and diseases.

Collaborations

Some of her notable coworkers include David V Schaffer and Bum-Yeol Hwang, who contribute to her research endeavors and help advance the field of gene therapy.

Conclusion

Melissa A Kotterman's innovative work in the field of gene therapy exemplifies the impact of scientific research on medical advancements. Her patents reflect a commitment to improving gene delivery systems, which could lead to significant breakthroughs in treating genetic conditions.